The tariff classification of Precision Flow Rate Tubing, High-Flo Subcutaneous Safety Needle Sets, and Adapter from Nicaragua
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the Precision Flow Rate Tubing will be 9018.90.8000, HTSUS, which provides for “Instruments and appliances used in medical, surgical, dental or veterinary sciences … parts and accessories thereof: other instruments and appliances and parts and accessories thereof: other: other.” The general rate of duty will be free.
- The applicable subheading for the Adapter will be 9018.90.8000, HTSUS, which provides for “Instruments and appliances used in medical, surgical, dental or veterinary sciences … parts and accessories thereof: other instruments and appliances and parts and accessories thereof: other: other.” The general rate of duty will be free.
Ruling text
In your letter dated March 31, 2026, you requested a tariff classification ruling on behalf of your client, Koru Medical Systems, Inc. The items in consideration are the Precision Flow Rate Tubing, High-Flo Subcutaneous Safety Needle Sets, and Adapter. The Precision Flow Rate Tubing is made of medical grade non-DEHP PVC tubing and features luer connectors and disposable plastic end caps on both ends, as well as a slide clamp.
It is designed to connect to a syringe on one end and, on the other end, to a High-Flo Needle Set or vascular access device. The plastic end caps help prevent contamination, and each Precision Flow Rate Tubing is individually packaged in a sterile pouch. Precision Flow Rate Tubing is specifically designed to work exclusively with Freedom60 and FreedomEdge Infusion Systems.
The High-Flo Subcutaneous Safety Needle Sets are single-use infusion sets consisting of a 90-degree stainless steel grade needle mounted to a butterfly assembly on one end, a PVC tubing, a slide clamp, and leur connectors on either end. High-Flo Subcutaneous Safety Needle Sets are intended for the subcutaneous infusion of liquid medicines from an external infusion pump or syringe.
The sets are packaged individually in terminally sterilized single barrier systems and available in multiple configurations with variations in needle gauge, wall thickness, number of needle legs, and needle lengths. High-Flo Subcutaneous Safety Needle Sets are specifically designed to work with Freedom60 and FreedomEdge Infusion Systems. The Adapter is a plastic molded article that is reusable and removable. It is intended to hold and position the syringe flange within the pump.
The Adapter is specifically designed for the Freedom 60 Infusion System. However, as you noted the Freedom60 Infusion System can also operate independently without the Adapter. The Freedom60 and FreedomEdge Infusion Systems are mechanically operated devices that require no batteries or electrical power. Using a constant-force spring mechanism, they deliver medication at a steady, controlled rate by applying consistent pressure to the syringe plunger.
Their portable design enables use in home, clinical and other settings by patients (adults, adolescents and pediatrics), caregivers, or healthcare providers. Based on your first submission, both infusion systems are specifically intended for patients with immunodeficiencies and certain neurological conditions and are indicated for Subcutaneous Immunoglobulin (SCIg) administration, Empaveli infusion for those suffering from Paroxysmal Nocturnal Hemoglobinuria (PNH) and intravenous (IV) antibiotic infusions.
They provide increased flexibility, allowing extended or lifelong treatment regimens to be managed outside of hospitals. This offers an alternative to intravenous (IV) immunoglobulin therapy, enabling subcutaneous administration in home environments. Your second submission states that the infusion systems are specifically designed to work with a limited set of medications, namely SCIg replacement therapies for individuals with Primary Immunodeficiency Disorders (PID).
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N360225).